Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation

Giulio La Rosa; Carlos A. Morillo; Jorge G. Quintanilla; Adelina Doltra; Lluı́s Mont; Moisés Rodríguez‐Mañero; Andrea Sarkozy; José Luís Merino; David Vivas; Tomás Datino; David de Gonzalo‐Calvo; Nicasio Pérez‐Castellano; Julián Pérez‐Villacastín; Laurent Fauchier; Professor Gregory Lip; Stéphane Hatem; José Jalife; Laura Sanchís; Francisco Marı́n; David Filgueiras‐Rama

doi:10.1016/j.rec.2024.02.009

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Letter2018

Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy

Hyunjean Jung, Jung‐Hoon Sung, Pil‐Sung Yang, Eunsun Jang, Hee Tae Yu, Tae‐Hoon Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung, Professor Gregory Lip

Article2019

Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study

Hyunjean Jung, Pil‐Sung Yang, Jung‐Hoon Sung, Eunsun Jang, Hee Joon Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Professor Gregory Lip, Boyoung Joung

Article2018

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy

Hyunjean Jung, Pil‐Sung Yang, Eunsun Jang, Hee Tae Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung, Professor Gregory Lip

Letter2019

To the Editor— Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?

Boyoung Joung, Professor Gregory Lip

Letter2017

Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks

Kazuo Miyazawa, Professor Gregory Lip